Ben-Shlomo S, Zvibel I, Rabinowich L, Goldiner I, Shlomai A, Santo EM, et al
Strongest human evidence The METAOD006 (OPTIONS) Phase 2b trial randomized 502 adults with obesity (BMI 30-45 kg/m^2) to oral AOD-9604 (0.25, 0.5, or 1 mg/day) or placebo for 24 weeks alongside a supervised diet and exercise program
Sympathetic nervous system effects may contribute to heart rate changes
Accessed 16 May 2024 Ministrio da Sade (2024) Boletim epidemiolgico da malria vol 55: Dia da Malria nas Amricas um panorama da malria no Brasil em 2022 e no primeiro semestre de 2023
Among the three stores compared, LeoLab RX provides the clearest public third-party testing visibility , supported by openly identified laboratory reports and batch-level verification